MAP2K7 and ovarian carcinoma: An inhibitor of the MAPK signal transduction pathway at MEK, PD 98059 (PD) (30 μM) inhibited the proliferative effect of thyroid hormone T3 and T4 on ovarian cancer cells SKOV-3 (Figure 3A).